{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:51:15Z","timestamp":1782953475839,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A correlation between various sites or types of mutations in mitochondrial DNA <jats:italic>ND3<\/jats:italic> and the development of a specific mitochondrial disease or phenotype has yet to be fully established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study reports a rare case of adult-onset Leigh syndrome (LS) and Leber hereditary optic neuropathy and dystonia (LDYT) overlap syndrome caused by the m.10197G&gt;A mutation in <jats:italic>ND3<\/jats:italic>. A review of the literature was conducted to investigate the clinical spectrum, treatment and outcome resulting from the m.10197G&gt;A mutation. Phenotypes associated with the m.10197G&gt;A mutation were classified into three categories: LS\/LS+ (LS-involved overlap syndrome), Leber hereditary optic neuropathy (LHON)\/LHON+ (LHON-involved overlap syndrome) and other mitochondrial encephalopathies or presentations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 84 participants (78 patients and 6 asymptomatic carriers) with the m.10197G&gt;A mutation retrieved from 33 articles and the patient whose case we reported were included in the review and meta-analysis. Among all the participants, 55.3% (47\/85) and 28.2% (24\/85) presented with LS\/LS+ and LHON\/LHON+, respectively. The median age at onset for LS\/LS+ was significantly younger than that for LHON\/LHON+ [median, (Q1\u2013Q3), 3.0 (0.58\u20139.5) vs. 13.5 (5.75\u201341.75), <jats:italic>P<\/jats:italic>\u2009=\u20090.001]. A negative linear correlation was observed between mutation load and age of onset in patients who presented with LS\/LS+ (R<jats:sup>2<\/jats:sup>\u2009=\u20090.592, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), with the age of onset ranging from infancy to adulthood. Patients with an older age at onset [OR (95% CI), 1.46 (1.12\u20131.91), <jats:italic>P<\/jats:italic>\u2009=\u20090.005] or higher mutation loads [OR (95% CI), 1.14 (1.03\u20131.26), <jats:italic>P<\/jats:italic>\u2009=\u20090.011] were more likely to present with LHON\/LHON+ than with LS\/LS+. A total of 17 patients were documented as having received a combination of mitochondrial cofactor treatments. Compared with patients with LHON\/LHON+, patients with LS\/LS+ exhibited an exceedingly high probability of a stable or worsen outcome (93.8% vs. 33.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>LS\/LS+ and LHON\/LHON+ are the predominant presentations of the m.10197G&gt;A mutation. An older age at onset and greater mutation load increases the probability of an LHON\/LHON+ presentation. Patients presenting with LS\/LS+ have an exceedingly high possibility of an unfavorable outcome. The identification of factors and outcomes associated with phenotypes in patients with the m.10197G&gt;A mutation facilitates the provision of improved prognostic counseling for patients and their family members who are carriers of this mutation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03588-5","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T09:32:42Z","timestamp":1739007162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical spectrum, treatment and outcomes of the m.10197G&gt;A mutation in MT-ND3: a case report, systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"YuZhi","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SongTao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinGao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0053-3451","authenticated-orcid":false,"given":"ZaiQiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"3588_CR1","doi-asserted-by":"publisher","first-page":"20160104","DOI":"10.1098\/rsfs.2016.0104","volume":"7","author":"A Galkin","year":"2017","unstructured":"Galkin A, Moncada S. Modulation of the conformational state of mitochondrial complex I as a target for therapeutic intervention. Interface Focus. 2017;7:20160104.","journal-title":"Interface Focus"},{"key":"3588_CR2","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1212\/WNL.52.6.1255","volume":"52","author":"DM Kirby","year":"1999","unstructured":"Kirby DM, Crawford M, Cleary MA, Dahl H-HM, Dennett X, Thorburn DR. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology. 1999;52:1255.","journal-title":"Neurology"},{"key":"3588_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1172\/JCI20683","volume":"114","author":"DM Kirby","year":"2004","unstructured":"Kirby DM, Salemi R, Sugiana C, et al. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Investig. 2004;114:837\u201345.","journal-title":"J Clin Investig"},{"key":"3588_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbabio.2008.10.001","volume":"1787","author":"L Valente","year":"2009","unstructured":"Valente L, Piga D, Lamantea E, et al. Identification of novel mutations in five patients with mitochondrial encephalomyopathy. Biochim Biophys Acta. 2009;1787:491\u2013501.","journal-title":"Biochim Biophys Acta"},{"key":"3588_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1203\/pdr.0b013e3180459f2d","volume":"61","author":"JH Chae","year":"2007","unstructured":"Chae JH, Lee JS, Kim KJ, et al. A novel ND3 mitochondrial DNA mutation in three Korean children with basal ganglia lesions and complex I deficiency. Pediatr Res. 2007;61:622\u20134.","journal-title":"Pediatr Res"},{"key":"3588_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10048-009-0194-0","volume":"10","author":"K Wang","year":"2009","unstructured":"Wang K, Takahashi Y, Gao ZL, et al. Mitochondrial ND3 as the novel causative gene for Leber hereditary optic neuropathy and dystonia. Neurogenetics. 2009;10:337\u201345.","journal-title":"Neurogenetics"},{"key":"3588_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/19401736.2014.905860","volume":"26","author":"Y Leng","year":"2015","unstructured":"Leng Y, Liu Y, Fang X, et al. The mitochondrial DNA 10197G>A mutation causes MELAS\/Leigh overlap syndrome presenting with acute auditory agnosia. Mitochondrial DNA. 2015;26:208\u201312.","journal-title":"Mitochondrial DNA"},{"key":"3588_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mito.2021.11.006","volume":"62","author":"Y Shi","year":"2022","unstructured":"Shi Y, Chen G, Sun D, et al. Phenotypes and genotypes of mitochondrial diseases with mtDNA variations in Chinese children: a multi-center study. Mitochondrion. 2022;62:139\u201350.","journal-title":"Mitochondrion"},{"key":"3588_CR9","doi-asserted-by":"publisher","first-page":"e18634","DOI":"10.1097\/MD.0000000000018634","volume":"99","author":"X Chang","year":"2020","unstructured":"Chang X, Wu Y, Zhou J, Meng H, Zhang W, Guo J. A meta-analysis and systematic review of Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations. Medicine. 2020;99:e18634.","journal-title":"Medicine"},{"key":"3588_CR10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/ene.15814","volume":"30","author":"A Ardissone","year":"2023","unstructured":"Ardissone A, Ferrera G, Lamperti C, et al. Phenotyping mitochondrial DNA-related diseases in childhood: a cohort study of 150 patients. Eur J Neurol. 2023;30:2079\u201391.","journal-title":"Eur J Neurol"},{"key":"3588_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13023-023-02632-6","volume":"18","author":"T Wong","year":"2023","unstructured":"Wong T, Belaramani KM, Chan C, et al. Mitochondrial diseases in Hong Kong: prevalence, clinical characteristics and genetic landscape. Orphanet J Rare Dis. 2023;18:43.","journal-title":"Orphanet J Rare Dis"},{"key":"3588_CR12","doi-asserted-by":"publisher","first-page":"1331351","DOI":"10.3389\/fcell.2024.1331351","volume":"12","author":"C Nogueira","year":"2024","unstructured":"Nogueira C, Pereira C, Silva L, et al. The genetic landscape of mitochondrial diseases in the next-generation sequencing era: a Portuguese cohort study. Front Cell Dev Biol. 2024;12:1331351.","journal-title":"Front Cell Dev Biol"},{"key":"3588_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jns.2019.04.005","volume":"400","author":"M Severino","year":"2019","unstructured":"Severino M, Nesti C, Rubegni A, Tolomeo D, Santorelli FM. The features of the m.10197G>A mtDNA mutation. J Neurol Sci. 2019;400:184\u20135.","journal-title":"J Neurol Sci"},{"key":"3588_CR14","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1111\/ene.15821","volume":"30","author":"C Durrleman","year":"2023","unstructured":"Durrleman C, Grevent D, Aubart M, et al. Clinical and radiological description of 120 pediatric stroke-like episodes. Eur J Neurol. 2023;30:2051\u201361.","journal-title":"Eur J Neurol"},{"key":"3588_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/genes15020188","volume":"15","author":"MJ Gilhooley","year":"2024","unstructured":"Gilhooley MJ, Raoof N, Yu-Wai-Man P, Moosajee M. Inherited optic neuropathies: real-world experience in the paediatric neuro-ophthalmology clinic. Genes (Basel). 2024;15:188.","journal-title":"Genes (Basel)"},{"key":"3588_CR16","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","volume":"66","author":"AM Schaefer","year":"2006","unstructured":"Schaefer AM, Phoenix C, Elson JL, McFarland R, Chinnery PF, Turnbull DM. Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology. 2006;66:1932\u20134.","journal-title":"Neurology"},{"key":"3588_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"3588_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313:1657\u201365.","journal-title":"JAMA"},{"key":"3588_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/humu.20846","volume":"30","author":"HJ Bandelt","year":"2009","unstructured":"Bandelt HJ, Salas A, Taylor RW, Yao YG. Exaggerated status of \u201cnovel\u201d and \u201cpathogenic\u201d mtDNA sequence variants due to inadequate database searches. Hum Mutat. 2009;30:191\u20136.","journal-title":"Hum Mutat"},{"key":"3588_CR20","first-page":"147","volume":"10","author":"SW Herman","year":"2015","unstructured":"Herman SW. Evidence summary: google scholar could be used as a stand-alone resource for systematic reviews. Donald Barbara Zucker Sch Med. 2015;10:147\u20139.","journal-title":"Donald Barbara Zucker Sch Med"},{"key":"3588_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ana.26313","volume":"91","author":"SL Stenton","year":"2022","unstructured":"Stenton SL, Zou Y, Cheng H, et al. Leigh syndrome: a study of 209 patients at the Beijing children\u2019s hospital. Ann Neurol. 2022;91:466\u201382.","journal-title":"Ann Neurol"},{"key":"3588_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.joco.2018.10.003","volume":"31","author":"M Fantini","year":"2019","unstructured":"Fantini M, Asanad S, Karanjia R, Sadun A. Hormone replacement therapy in Leber\u2019s hereditary optic neuropathy: accelerated visual recovery in vivo. J Curr Ophthalmol. 2019;31:102\u20135.","journal-title":"J Curr Ophthalmol"},{"key":"3588_CR23","doi-asserted-by":"publisher","first-page":"1000673","DOI":"10.4172\/2155-9570.1000673","volume":"8","author":"TL Huang","year":"2017","unstructured":"Huang TL, Wang JK, Yoong Pang C, Tsai RK. Leber\u2019s hereditary optic neuropathy associated with the m.10197G>A mutation. J Clin Exp Ophthalmol. 2017;8:1000673.","journal-title":"J Clin Exp Ophthalmol."},{"key":"3588_CR24","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3892\/mmr.2014.2911","volume":"11","author":"Z Chen","year":"2015","unstructured":"Chen Z, Zhao Z, Ye Q, et al. Mild clinical manifestation and unusual recovery upon coenzyme Q10 treatment in the first Chinese Leigh syndrome pedigree with mutation m.10197 G>A. Mol Med Rep. 2015;11:1956\u201362.","journal-title":"Mol Med Rep"},{"key":"3588_CR25","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1007\/s00415-018-9014-5","volume":"265","author":"Y Wei","year":"2018","unstructured":"Wei Y, Cui L, Peng B. Mitochondrial DNA mutations in late-onset Leigh syndrome. J Neurol. 2018;265:2388\u201395.","journal-title":"J Neurol"},{"key":"3588_CR26","doi-asserted-by":"publisher","first-page":"119363","DOI":"10.1016\/j.jns.2021.119363","volume":"429","author":"E Cipriano","year":"2021","unstructured":"Cipriano E, Vecchio D, Mazzini L, et al. A young male with walking difficulties and subacute brainstem dysfunction: adult-onset Leigh syndrome. J Neurol Sci. 2021;429:119363.","journal-title":"J Neurol Sci"},{"key":"3588_CR27","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1007\/s10072-022-06305-3","volume":"43","author":"Y Wei","year":"2022","unstructured":"Wei Y, Qian M, Yang Y. Extended spinal cord involvement in adult-onset Leigh syndrome due to mitochondrial 10197G >A mutation. Neurol Sci. 2022;43:6997\u20137000.","journal-title":"Neurol Sci"},{"key":"3588_CR28","doi-asserted-by":"publisher","first-page":"648740","DOI":"10.3389\/fneur.2021.648740","volume":"12","author":"Y Wei","year":"2021","unstructured":"Wei Y, Huang Y, Yang Y, Qian M. MELAS\/LS overlap syndrome associated with mitochondrial DNA mutations: clinical, genetic, and radiological studies. Front Neurol. 2021;12:648740.","journal-title":"Front Neurol"},{"key":"3588_CR29","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/brain\/awae057","volume":"147","author":"B Blickh\u00e4user","year":"2024","unstructured":"Blickh\u00e4user B, Stenton SL, Neuhofer CM, et al. Digenic Leigh syndrome on the background of the m.11778G>A Leber hereditary optic neuropathy variant. Brain. 2024;147:1967\u201374.","journal-title":"Brain"},{"key":"3588_CR30","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.3390\/ijms25094602","volume":"25","author":"CM Neuhofer","year":"2024","unstructured":"Neuhofer CM, Prokisch H. Digenic inheritance in rare disorders and mitochondrial disease\u2014crossing the frontier to a more comprehensive understanding of etiology. Int J Mol Sci. 2024;25:4602.","journal-title":"Int J Mol Sci"},{"key":"3588_CR31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41433-021-01535-9","volume":"36","author":"P Yu-Wai-Man","year":"2022","unstructured":"Yu-Wai-Man P, Newman NJ, Carelli V, et al. Natural history of patients with Leber hereditary optic neuropathy\u2014results from the REALITY study. Eye. 2022;36:818\u201326.","journal-title":"Eye"},{"key":"3588_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.tig.2020.06.009","volume":"36","author":"KR Schon","year":"2020","unstructured":"Schon KR, Ratnaike T, van den Ameele J, Horvath R, Chinnery PF. Mitochondrial diseases: a diagnostic revolution. Trends Genet. 2020;36:702\u201317.","journal-title":"Trends Genet"},{"key":"3588_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/WNO.0000000000000714","volume":"39","author":"O Solyman","year":"2019","unstructured":"Solyman O, MacIntosh P. Leber hereditary optic neuropathy in a mother and daughter associated with m.10197G>A mutation. J Neuro-Ophthal. 2019;39:142.","journal-title":"J Neuro-Ophthal"},{"key":"3588_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1042\/bj20021594","volume":"370","author":"R Rossignol","year":"2003","unstructured":"Rossignol R, Faustin B, Rocher C, Malgat M, Mazat J-P, Letellier T. Mitochondrial threshold effects. Biochem J. 2003;370:751\u201362.","journal-title":"Biochem J"},{"key":"3588_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/mdc3.13165","volume":"8","author":"F Magrinelli","year":"2021","unstructured":"Magrinelli F, Balint B, Bhatia KP. Challenges in clinicogenetic correlations: one gene\u2014many phenotypes. Mov Disord Clin Pract. 2021;8:299\u2013310.","journal-title":"Mov Disord Clin Pract"},{"key":"3588_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/EJE-20-0189","volume":"183","author":"HW Chae","year":"2020","unstructured":"Chae HW, Na JH, Kim HS, Lee YM. Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome. Eur J Endocrinol. 2020;183:505\u201312.","journal-title":"Eur J Endocrinol"},{"key":"3588_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/joim.13064","volume":"287","author":"C La Morgia","year":"2020","unstructured":"La Morgia C, Maresca A, Caporali L, Valentino ML, Carelli V. Mitochondrial diseases in adults. J Intern Med. 2020;287:592\u2013608.","journal-title":"J Intern Med"},{"key":"3588_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.62.7.22","volume":"62","author":"X Jin","year":"2021","unstructured":"Jin X, Zhang J, Yi Q, et al. Leber\u2019s hereditary optic neuropathy arising from the synergy between ND1 3635G>A mutation and mitochondrial YARS2 mutations. Investig Opthalmol Vis Sci. 2021;62:22.","journal-title":"Investig Opthalmol Vis Sci"},{"key":"3588_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/archneur.59.2.264","volume":"59","author":"V Carelli","year":"2002","unstructured":"Carelli V, Baracca A, Barogi S, et al. Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation. Arch Neurol. 2002;59:264\u201370.","journal-title":"Arch Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03588-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03588-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03588-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T09:32:44Z","timestamp":1739007164000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03588-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3588"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03588-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work is an observational study. The Beijing Tiantan Hospital Research Ethics Committee has confirmed that no ethical approval was needed. Written informed consent was obtained from the patient and his parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient and his parents gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}